首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Study on Effect of Small Dosage Tripterygium Glycosides in Auxiliary Treatment of Intractable Still's Disease
【24h】

Study on Effect of Small Dosage Tripterygium Glycosides in Auxiliary Treatment of Intractable Still's Disease

机译:小剂量雷公藤多甙辅助治疗顽固性Still病的效果研究

获取原文
获取原文并翻译 | 示例
       

摘要

Intractable Still's disease, namely the intractable systemic juvenile idiopathic arthritis (JIA) is a clinical difficulty of pediatrics, and so far there still lacks any special treatment. In virtue of the markedly anti-inflammatory and immunosuppres-sive effects of tripterygium glycosides (TG, product of Huangshi Pharmaceutical Factory, 10 mg/ tab), it is applied in treating many kinds of connective tissue diseases in China, and it has also been used to treat various types of JIA for many years. But systematic study on its clinical therapeutic effect to Still' s disease in children has not been reported till now. In this study, with prospective comparative analysis adopted, the author had studied the therapeutic effect of small dosage TG on JIA reported.
机译:顽固性斯蒂尔氏病,即顽固性全身性幼年特发性关节炎(JIA),是小儿科的临床难点,到目前为止,仍缺乏任何特殊的治疗方法。雷公藤多甙(TG,黄石制药厂生产,10 mg / tab)具有显着的抗炎和免疫抑制作用,在中国治疗多种结缔组织疾病中也得到了应用。过去多年用于治疗各种类型的JIA。但是到目前为止,尚无关于其对儿童斯蒂尔氏病临床疗效的系统研究。在这项研究中,通过前瞻性比较分析,作者研究了小剂量TG对JIA的治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号